Cargando…

First-line systemic therapy for advanced gastric cancer: a systematic review and network meta-analysis

BACKGROUND: Systemic therapy is the standard treatment against advanced gastric cancer. Fluoropyrimidine plus platinum doublet has been recommended as the preferred first-line strategy. However, there is still a lack of a comprehensive and hierarchical evidence that compares all eligible literature...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Ji, Cai, Ming, Shuai, Xiaoming, Gao, Jinbo, Wang, Guobin, Tao, Kaixiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Meta-Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767753/ https://www.ncbi.nlm.nih.gov/pubmed/31632469 http://dx.doi.org/10.1177/1758835919877726

Ejemplares similares

Multimodal treatments for resectable esophagogastric junction cancer: a systematic review and network meta-analysis
por: Cheng, Ji, et al.
Publicado: (2019)

Tumor-infiltrating immune cells and prognosis in gastric cancer: a systematic review and meta-analysis
por: Jiang, Wen, et al.
Publicado: (2017)

Homeobox protein CDX2 as a prognostic biomarker in solid malignancies: a meta-analysis
por: Yuan, Jingsheng, et al.
Publicado: (2017)

The role of anti-EGFR agents in the first-line treatment of advanced esophago-gastric adenocarcinoma: a meta-analysis
por: Kim, Bum Jun, et al.
Publicado: (2017)

Network meta-analysis of the efficacy of first-line chemotherapy regimens in patients with advanced colorectal cancer
por: Wu, Dong-Mei, et al.
Publicado: (2017)

First-line treatments for patients with advanced ALK gene rearrangements in NSCLC: a systematic review and network meta-analysis
por: Tao, Jiahao, et al.
Publicado: (2022)

Comparative effectiveness of first-line therapies for eradication of antibiotic-resistant Helicobacter pylori strains: A network meta-analysis
por: Zou, Shu-Peng, et al.
Publicado: (2022)

Selection of first-line systemic therapies for advanced hepatocellular carcinoma: A network meta-analysis of randomized controlled trials
por: Han, Yue, et al.
Publicado: (2021)

First-Line Systemic Therapies for Advanced Hepatocellular Carcinoma: A Systematic Review and Patient-Level Network Meta-Analysis
por: Fong, Khi Yung, et al.
Publicado: (2022)

Targeted first-line therapies for advanced colorectal cancer: a Bayesian meta-analysis
por: Ridouane, Yassine, et al.
Publicado: (2017)

Challenges in conducting fractional polynomial and standard parametric network meta-analyses of immune checkpoint inhibitors for first-line advanced renal cell carcinoma
por: Petersohn, Svenja, et al.
Publicado: (2023)

Efficacy and safety comparison of chemotherapies for advanced gastric cancer: A network meta-analysis
por: Sun, Jinping, et al.
Publicado: (2017)

Front-line treatment for advanced non-small-cell lung cancer and ALK fusion: a network meta-analysis
por: Wen, Yaokai, et al.
Publicado: (2022)

Comparative efficacy and tolerability of adjuvant systemic treatments against resectable colon cancer: a network meta-analysis
por: Cheng, Ji, et al.
Publicado: (2020)

Irinotecan Monotherapy Versus Irinotecan-Based Combination as Second-Line Chemotherapy in Advanced Gastric Cancer: A Meta-Analysis
por: Cho, Yo-Han, et al.
Publicado: (2017)

Pemetrexed/carboplatin plus gefitinib as a first-line treatment for EGFR-mutant advanced nonsmall cell lung cancer: a Bayesian network meta-analysis
por: Zhang, Zhonghan, et al.
Publicado: (2019)

Second-line chemotherapy for the treatment of metastatic pancreatic cancer after first-line gemcitabine-based chemotherapy: a network meta-analysis
por: Citterio, Chiara, et al.
Publicado: (2018)

Is there a preferred first-line therapy for metastatic renal cell carcinoma? A network meta-analysis
por: Cattrini, Carlo, et al.
Publicado: (2021)

Network meta-analysis of immune-oncology monotherapy as first-line treatment for advanced non-small-cell lung cancer in patients with PD-L1 expression ⩾50%
por: Freemantle, Nick, et al.
Publicado: (2022)

Prognostic significance of AMPK in human malignancies: A meta-analysis
por: Cheng, Ji, et al.
Publicado: (2016)

The efficacy and safety of first-line therapies for preventing chronic post-surgical pain: a network meta-analysis
por: Ning, Jie, et al.
Publicado: (2017)

Comparison of the profiles of first-line PD-1/PD-L1 inhibitors for advanced NSCLC lacking driver gene mutations: a systematic review and Bayesian network meta-analysis
por: Wenfan, Fu, et al.
Publicado: (2023)

Milk/dairy products consumption and gastric cancer: an update meta-analysis of epidemiological studies
por: Wang, Shuai, et al.
Publicado: (2017)

Systematic review of first-line chemotherapy for chemo-naïve extensive-stage small-cell lung cancer: network meta-analysis
por: Chen, Hao, et al.
Publicado: (2020)

First-line therapeutic strategy for patients with advanced non–small cell lung cancer with Leu858Arg epidermal growth factor receptor mutations: a Bayesian network meta-analysis
por: Chen, Chongxiang, et al.
Publicado: (2022)

Comparison of neoadjuvant chemotherapy followed by surgery vs. surgery alone for locally advanced gastric cancer: a meta-analysis
por: Yu, Jian-Hong, et al.
Publicado: (2021)

What is the quantitative risk of gastric cancer in the first-degree relatives of patients? A meta-analysis
por: Yaghoobi, Mohammad, et al.
Publicado: (2017)

Alcohol drinking and gastric cancer risk: a meta-analysis of observational studies
por: Wang, Peng-Liang, et al.
Publicado: (2017)

Two-dimensional versus three-dimensional laparoscopy in surgical efficacy: a systematic review and meta-analysis
por: Cheng, Ji, et al.
Publicado: (2016)

Network meta-analysis of the efficacy and adverse effects of several treatments for advanced/metastatic prostate cancer
por: Wu, Jing, et al.
Publicado: (2017)

Efficacy and safety of intraperitoneal chemotherapy in patients with advanced gastric cancer: a cumulative meta-analysis of randomized controlled trials
por: He, Zheng, et al.
Publicado: (2017)

Application of enhanced recovery after gastric cancer surgery: An updated meta-analysis
por: Wang, Liu-Hua, et al.
Publicado: (2018)

The comprehensive summary of surgical versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomized controlled trials
por: Cheng, Ji, et al.
Publicado: (2016)

Treatments for patients with advanced neuroendocrine tumors: a network meta-analysis
por: Liu, Tingting, et al.
Publicado: (2019)

The addition of bevacizumab in the first-line treatment for metastatic colorectal cancer: an updated meta-analysis of randomized trials
por: Jang, Hyun Joo, et al.
Publicado: (2017)

Is FOLFOXIRI alone or combined with targeted therapy administered as first-line treatment a reasonable choice for most patients with mCRC? Systematic review and network meta-analysis
por: Zhou, Mingyi, et al.
Publicado: (2017)

Docetaxel, cisplatin, and 5-fluorouracil compared with epirubicin, cisplatin, and 5-fluorouracil regimen for advanced gastric cancer: A systematic review and meta-analysis
por: Li, Bo, et al.
Publicado: (2019)

Efficacy and safety of first-line PD-1/PD-L1 inhibitor combinations for extensive-stage small-cell lung cancer: a Bayesian network meta-analysis
por: Li, Huijuan, et al.
Publicado: (2023)

The meta and bioinformatics analysis of GRP78 expression in gastric cancer
por: Zheng, Hua-Chuan, et al.
Publicado: (2017)

Adjuvant Chemotherapy for Advanced Gastric Cancer in Elderly and Non-elderly Patients: Meta-Analysis of Randomized Controlled Trials
por: Chang, Seong-Hwan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vac0cuk27235bcn5v7cstvv5pb